GLAXF Glaxosmithkline PLC: institutional ownership and insider trading

2 funds reported holding $70.1M of Glaxosmithkline PLC in their latest 13F filings; in Q2 2026 funds net sold $5.12M, with 0 new positions and 0 funds selling out.

Largest institutional holders of GLAXF

1. Aristotle Capital Management, LLC — $69.3M
2. Generali Investments CEE, investicni spolecnost, a.s. — $896K

5%+ owners

• FMR LLC: 5.8% (Schedule 13G, filed May 6, 2026)

All GLAXF 13F holders